Arbutus Biopharma
ABUS
#6610
Rank
NZ$1.17 B
Marketcap
NZ$6.11
Share price
-5.80%
Change (1 day)
2.75%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2025 (TTM): NZ-$0.44

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is NZ-$0.43. In 2024 the company made an earnings per share (EPS) of NZ-$0.64 an increase over its 2023 EPS that were of NZ-$0.74.

EPS history for Arbutus Biopharma from 1998 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.44-30.84%
2024NZ-$0.64-13.64%
2023NZ-$0.74-4.35%
2022NZ-$0.77-44.58%
2021NZ-$1.39-17%
2020NZ-$1.67-65.4%
2019NZ-$4.83138.84%
2018NZ-$2.02-22.44%
2017NZ-$2.61-78.45%
2016NZ-$12.11424.64%
2015NZ-$2.31-20.19%
2014NZ-$2.8987.96%
2013NZ-$1.54-142.59%
2012NZ$3.61-342.7%
2011NZ-$1.49-25.82%
2010NZ-$2.0147.8%
2009NZ-$1.36-43.55%
2008NZ-$2.40158.91%
2007NZ-$0.93-111.88%
2006NZ$7.82-552.53%
2005NZ-$1.73-71.77%
2004NZ-$6.12-14.48%
2003NZ-$7.16-8.95%
2002NZ-$7.8670.07%
2001NZ-$4.6248.01%
2000NZ-$3.12-38.54%
1999NZ-$5.08-24.6%
1998NZ-$6.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
NZ-$0.10-76.92% Bahamas
NRC Health
NRC
NZ$1.17-369.23%๐Ÿ‡บ๐Ÿ‡ธ USA